German High-Grade Non-Hodgkin's Lymphoma Study Group
1
Heidelberg University
1
Hoffmann-La Roche
1
III. Medizinische Klinik Mannheim
1
Clinical Trials at Haematologische Praxis
During the past decade, Haematologische Praxis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Haematologische Praxis" #1 sponsor was "German CLL Study Group" with 4 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials
sponsored, "Heidelberg University" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "III. Medizinische Klinik Mannheim"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Haematologische Praxis"
#1 collaborator was "German CLL Study Group" with 1 trials as a collaborator and "University of Cologne" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Haematologische Praxis
According to Clinical.Site data, the most researched conditions in "Haematologische Praxis" are
"Chronic Lymphocytic Leukemia" (4 trials), "Leukemia" (3 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Haematologische Praxis" in a lesser frequency.
Clinical Trials Intervention Types at Haematologische Praxis
Most popular intervention types in "Haematologische Praxis" are "Drug" (8 trials), "Biological" (4 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Fludarabine" (3 trials), "Rituximab" (2 trials), "allogeneic bone marrow transplantation" (2 trials), "cyclophosphamide" (2 trials) and "cytarabine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Haematologische Praxis
The vast majority of trials in "Haematologische Praxis" are
8 trials for "All" genders.
Clinical Trials Status at Haematologische Praxis
Currently, there are NaN active trials in "Haematologische Praxis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Haematologische Praxis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Haematologische Praxis, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".